2006, Number 5
<< Back Next >>
salud publica mex 2006; 48 (5)
Mortality due to influenza and pneumonia in Mexico between 1990 and 2005
Kuri-Morales P, Galván F, Cravioto P, Zárraga RLA, Tapia-Conyer R
Language: Spanish
References: 20
Page: 379-384
PDF size: 93.22 Kb.
ABSTRACT
Objective. To estimate the impact of influenza vaccine in infants less than two years of age and in elders more than sixty-five years of age, through the analysis of mortality due to influenza and pneumonia in Mexico, between 1990 and 2005. To determine the seasonal pattern of mortality, the tendency of mortality by volume of deaths per seasonal period, and the speed rate of mortality.
Material and methods. Data were taken from the Epidemiological and Statistical Mortality System (SEED-SSA per its abbreviation in Spanish).
Results and conclusions. The analysis showed there is a tendency of deaths decrease at a rate of 509 deaths less per year in the infants group and 29 deaths less in the elders group. Also, the ascending tendency of mortality was interrupted by vaccination. The vaccination intervention has a positive economic effect and also helps improve the quality of life. Therefore, its implementation is expected to lower hospital admissions and deaths.
REFERENCES
Ministerio de Sanidad y Consumo. Plan Nacional de Preparación y Respuesta ante una Pandemia de Gripe. España 2005. Disponible en: http:/www.msc.es/enfermedadeslesiones/enftransmisi/planpandemiagripeespañol.pdf.
Kusznierz GF, Imaz MS, Zerbini EV, Savy V, Knez V, Sequeira MD. Effect of influenza epidemics on mortality in Santa Fe, Argentina, during 1992-1999. Rev Panam Salud Publica 2002;12(1):26-36
Manjarrez ZM, Arenas LG. Virus influenza: enigma del pasado y del presente. Rev Inst Nal Enf Resp Mex 1999;12(4):290-299.
Hollenbek JE. An avian connection as a catalyst to the 1918-1919 influenza pandemic. Int J Med Sci 2005;2(2):87-90.
Vilma L. Plan de preparación para la epidemia de influenza. El rol de la Organización Mundial de la Salud y Guías para la planificación Nacional y Regional. Ginebra, Suiza 1999. Disponible en: http://www.who.int/csr/resourses/publication/influenza/whoplanspanish.pdf.
Barriga AG, Arumir EC, Mercado GF. Influenza aviaria ¿la primera pandemia del siglo XXI?. Rev Mex Patol Clin 2004;51(1):16-23.
Velazco CJ, Medina GC. La prevención de la influenza. Medicina universitaria 2000;2(7):148-155.
Jofre ML, Perret PC, Dabanch PJ, Abarca VK, Olivares CR, Luchsinger FV, et al. Influenza: reemergencia de una antigua enfermedad y el potencial riesgo de una nueva epidemia. Rev Chil Infect 2005;22(1):75-88.
Talavera GA, Gongora BR, Lopez MI, et al. Detention of human influenza virus in Yucatan, Mexico. Rev Invest Clin 2002;54(5):410-419.
Piñón RA, Oropesa FS, Aragonés LC, et al. Influenza y vacunación. Rev Biomed 2005;16(1):45-53.
Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals-A randomized double-lind placebo-controlled trial. JAMA 1994;272:1661-1665.
Nichol KL, Margolis KL, Wuorenma J, Von Stenberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons in the community. N Engl J Med 1994;331:778-784.
Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review if the literature. Ann Intern Med 1995;123:517-528.
Bergamo FP, Camargo DM, Dias LM. Impact of influenza vaccination on mortality by respiratory diseases among Brazilian elderly persons. Rev Saude Pulica 2005;39(1):1-6.
Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004;190:1-10.
Vordoouw AC, Sturkenboom MC, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004;292:2089-2095.
Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-1836.
Gutiérrez JP, Bertozzi SM. Vacunación contra influenza para adultos mayores en México: consideraciones económicas. Salud Publica Mex 2005;47(3):234-239.
Goronzy JJ, Fulbrigh JW, Crowson CS, et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001;75:12182-12187.
Simonsen L, Reicher TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005;165:265-272.